Shanshan Xie Selected Research

Shanshan Xie Research Topics

Disease

15	Neoplasms (Cancer) 02/2024 - 03/2013
5	Inflammation (Inflammations) 06/2023 - 08/2009
3	Insulin Resistance 12/2023 - 08/2008
3	Obesity 12/2023 - 05/2017
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 11/2020
3	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 02/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 08/2009
2	Heart Failure 12/2023 - 10/2021
2	Glioma (Gliomas) 02/2023 - 10/2017
2	Reperfusion Injury 01/2023 - 11/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 11/2020
2	Rotator Cuff Injuries 01/2023 - 09/2022
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Pain (Aches) 01/2022 - 01/2020
2	Adenocarcinoma 02/2021 - 04/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2018
1	Intellectual Disability (Idiocy) 05/2024
1	Prostatic Neoplasms (Prostate Cancer) 03/2024
1	Dyspnea (Shortness of Breath) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2023
1	Infarction (Infarctions) 01/2023
1	Ciliopathies 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Placenta Accreta 10/2022
1	Persistent Infection 06/2022
1	Pathologic Processes 06/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Papillary Thyroid Cancer 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Atrophic Gastritis 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 12/2023 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 08/2008
5	AntigensIBA 11/2021 - 02/2013
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
3	RNA (Ribonucleic Acid)IBA 08/2023 - 10/2019
3	MicroRNAs (MicroRNA)IBA 06/2022 - 11/2020
3	MesothelinIBA 04/2018 - 02/2016
2	TubulinIBA 03/2024 - 02/2024
2	Antisense OligonucleotidesIBA 12/2023 - 08/2023
2	Messenger RNA (mRNA)IBA 08/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2023 - 11/2020
2	CholesterolIBA 09/2022 - 01/2022
2	Mechanistic Target of Rapamycin Complex 1IBA 09/2022 - 01/2022
2	Estrogen ReceptorsIBA 01/2022 - 01/2021
2	AcidsIBA 01/2022 - 01/2018
2	CytokinesIBA 01/2022 - 02/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 11/2021
2	6-methyladenineIBA 12/2020 - 11/2020
2	Insulin (Novolin)FDA Link 05/2017 - 08/2008
2	insect maxadilan proteinIBA 08/2009 - 08/2008
1	ChromatinIBA 05/2024
1	Histone ChaperonesIBA 05/2024
1	millepachineIBA 03/2024
1	Histone Deacetylase InhibitorsIBA 03/2024
1	Adenosine Triphosphatases (ATPase)IBA 02/2024
1	Nucleic AcidsIBA 12/2023
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 12/2023
1	Nicorandil (SG 75)IBA 12/2023
1	Small Interfering RNA (siRNA)IBA 08/2023
1	Nucleotide AptamersIBA 08/2023
1	erucylphosphocholineIBA 06/2023
1	Ion Channels (Ion Channel)IBA 02/2023
1	Potassium Channels (Potassium Channel)IBA 02/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	ChloridesIBA 01/2023
1	Sirtuin 3IBA 01/2023
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2023
1	ProteomeIBA 01/2023
1	tetramethylpyrazineIBA 01/2023
1	Colchicine FDA LinkGeneric 12/2022
1	deoxypodophyllotoxinIBA 12/2022
1	Tubulin ModulatorsIBA 12/2022
1	NitrogenIBA 10/2022
1	Urea (Carbamide)FDA LinkGeneric 10/2022
1	CreatinineIBA 10/2022
1	Phosphates (Orthophosphate)IBA 09/2022
1	BuffersIBA 09/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	catalpolIBA 02/2022
1	Blood Glucose (Blood Sugar)IBA 02/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	methylureaIBA 01/2022
1	Pepsinogen A (Pepsinogen)IBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	GastrinsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022

Therapy/Procedure

9	Therapeutics 08/2023 - 02/2016
4	Immunotherapy 02/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 03/2024 - 04/2018
2	Aftercare (After-Treatment) 12/2023 - 01/2022
1	Blood Transfusion (Blood Transfusions) 10/2022
1	Hysterectomy 10/2022